Diagnos Laboratorium Utama Tbk. vs Suryamas Dutamakmur Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Suryamas Dutamakmur Tbk. trades at Rp565 (market cap 2.72T, 32.2K 24h volume). The key difference: Suryamas Dutamakmur Tbk. is far larger — about 8.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 32.2K). Which is the better fit depends on your goals.
| DGNS | SMDM | |
|---|---|---|
Market Cap | 310.75B | 2.72T |
Volume | 963.6K | 32.2K |
Lot | 9.64K | 322 |
Turnover | 217.67M | 18.19M |
Average Price | 225.89 | 564.97 |
Value | 217.67M | 18.19M |
Indicative Equilibrium Price | 226 | 565 |
Indicative Equilibrium Volume | 1K | 12 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Suryamas Dutamakmur Tbk (the Company) was established based on notarial Deed No. 322, dated September 21, 1989 of Benny Kristianto, S.H., notary in Jakarta. PT. Suryamas Dutamakmur has a specific aim to participate in meeting the growing demand for quality residential development in the Greater Jakarta area.
Read more on SMDM →